Express Scripts Holding Company (NASDAQ:ESRX) – Analysts at Jefferies Group boosted their FY2017 earnings per share estimates for Express Scripts in a research report issued on Friday. Jefferies Group analyst B. Tanquilut now expects that the company will post earnings of $7.04 per share for the year, up from their previous forecast of $7.02. Jefferies Group currently has a “Buy” rating and a $80.00 target price on the stock. Jefferies Group also issued estimates for Express Scripts’ Q4 2017 earnings at $2.08 EPS, Q1 2018 earnings at $1.48 EPS, Q2 2018 earnings at $1.88 EPS, Q3 2018 earnings at $2.10 EPS, Q4 2018 earnings at $2.30 EPS and FY2018 earnings at $7.77 EPS.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.90. The firm had revenue of $24.68 billion for the quarter, compared to analyst estimates of $25.68 billion. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The business’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.74 EPS.
Several other equities research analysts have also weighed in on the stock. TheStreet raised shares of Express Scripts from a “c+” rating to a “b-” rating in a report on Monday, December 4th. ValuEngine raised shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Monday, December 4th. Deutsche Bank initiated coverage on shares of Express Scripts in a report on Monday, December 4th. They issued a “buy” rating and a $75.00 target price on the stock. Zacks Investment Research raised shares of Express Scripts from a “hold” rating to a “buy” rating and set a $64.00 target price on the stock in a report on Monday, October 16th. Finally, BidaskClub raised shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Thursday. Five equities research analysts have rated the stock with a sell rating, ten have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $74.40.
Shares of Express Scripts (NASDAQ:ESRX) opened at $71.55 on Monday. The stock has a market cap of $40,523.99, a price-to-earnings ratio of 10.46, a price-to-earnings-growth ratio of 1.06 and a beta of 0.88. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. Express Scripts has a fifty-two week low of $55.80 and a fifty-two week high of $73.42.
A number of institutional investors have recently added to or reduced their stakes in the business. Dodge & Cox lifted its position in Express Scripts by 25.7% during the 2nd quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock valued at $2,310,275,000 after purchasing an additional 7,388,021 shares during the period. Macquarie Group Ltd. lifted its position in Express Scripts by 8.4% during the 2nd quarter. Macquarie Group Ltd. now owns 11,880,919 shares of the company’s stock valued at $758,480,000 after purchasing an additional 922,406 shares during the period. Northern Trust Corp lifted its position in Express Scripts by 12.2% during the 2nd quarter. Northern Trust Corp now owns 11,068,777 shares of the company’s stock valued at $706,629,000 after purchasing an additional 1,206,980 shares during the period. Veritas Asset Management LLP lifted its position in Express Scripts by 5.6% during the 3rd quarter. Veritas Asset Management LLP now owns 8,652,910 shares of the company’s stock valued at $547,902,000 after purchasing an additional 460,338 shares during the period. Finally, Nordea Investment Management AB lifted its position in Express Scripts by 2.6% during the 3rd quarter. Nordea Investment Management AB now owns 7,304,973 shares of the company’s stock valued at $462,551,000 after purchasing an additional 188,528 shares during the period. Institutional investors own 88.44% of the company’s stock.
In related news, CEO Timothy C. Wentworth purchased 8,000 shares of Express Scripts stock in a transaction that occurred on Tuesday, October 31st. The shares were acquired at an average price of $61.13 per share, for a total transaction of $489,040.00. Following the transaction, the chief executive officer now directly owns 98,628 shares in the company, valued at $6,029,129.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP Phyllis S. Anderson sold 643 shares of the company’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total transaction of $40,103.91. The disclosure for this sale can be found here. 0.68% of the stock is owned by corporate insiders.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.